Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as carboxymethylcellulose based eye drop formula
carboxymethylcellulose based eye formula · 1 trial · 1 indication
Contact lens distance visual acuity was measured for each eye using the LogMAR visual acuity eye chart. The worse eye at Baseline was used for analysis. A change of 0.1 on the LogMAR scale was equivalent to a 1 line change in visual acuity. The following categories are reported: Better=an increase in 2 or more lines, No Change=a change of +/- 1 line, and Worse=a decrease of 2 lines or more.
| Arm | Type | Description |
|---|---|---|
| Carboxymethylcellulose Based Eye Drop Formula | EXPERIMENTAL | 1-2 drops of carboxymethylcellulose based eye drop formula in each eye, a minimum of 4 times a day for 90 days. One of the 4 times a day may be to prepare the contact lens for insertion. |
| REFRESH CONTACTS® | ACTIVE_COMPARATOR | 1-2 drops carboxymethylcellulose sodium based eye drop solution (REFRESH CONTACTS®) in each eye, a minimum of 4 times a day for 90 days. One of the 4 times a day may be to prepare the contact lens for insertion. |
| Name | Type | Description |
|---|---|---|
| carboxymethylcellulose based eye drop formula | DRUG | 1-2 drops of carboxymethylcellulose based eye drop formula in each eye, a minimum of 4 times a day for 90 days. One of the 4 times a day may be to prepare the contact lens for insertion. |
| carboxymethylcellulose sodium based eye drop solution | DRUG | 1-2 drops carboxymethylcellulose sodium based eye drop solution (REFRESH CONTACTS®) in each eye, a minimum of 4 times a day for 90 days. One of the 4 times a day may be to prepare the contact lens for insertion. |
Inclusion Criteria: -Adapted contact wearer with daily usage of at least 6 hours a day, 5 days a week. Exclusion Criteria: * Wearing monovision lenses * Have had refractive surgery within the previous 12 months * Have infection of the eye, eyelids or eye structures.
Carboxymethylcellulose based eye formula is an investigational small molecule eye drop developed by AbbVie Inc. (ticker: ABBV) for contact lens lubrication. It is designed to lubricate the eye while contact lenses are worn. The formula is in Phase 3 clinical development and has been studied in a completed trial.
Carboxymethylcellulose based eye formula is used for contact lens lubrication. It is intended to provide lubrication for contact lens wearers. The indication studied in its clinical trial was contact lens lubrication, and the trial enrolled 365 participants.
AbbVie Inc. (ticker: ABBV) makes carboxymethylcellulose based eye formula. AbbVie is the developer of this investigational eye drop. The company is responsible for its clinical development.
Carboxymethylcellulose based eye formula is in Phase 3 clinical development. It is investigational and has not been approved by the FDA. One Phase 3 trial has been completed, and no active trials are currently listed.
Carboxymethylcellulose based eye formula has been studied in one completed Phase 3 trial, NCT01844388, titled A Study to Compare a New Eye Drop Formulation With Refresh Contacts. The trial enrolled 365 participants in the United States and was randomized, double-blind, and active-controlled.
Yes, carboxymethylcellulose based eye formula is also known as carboxymethylcellulose based eye drop formula. Both names refer to the same investigational eye drop developed by AbbVie Inc. for contact lens lubrication.